Established in 1997, S.L.A. Pharma AG is one of the few pharmaceutical companies in the world focused solely on developing medicines for the prevention and treatment of gastrointestinal disorders.
S.L.A. Pharma is a privately owned company, located outside Basel in Switzerland with an operations arm in the UK. Our dedicated team includes experienced pharmaceutical, medical and regulatory professionals with the required knowledge and expertise to drive the product from conception through to launch.
Working alongside a global network of top gastroenterologists and colorectal surgeons – offering outstanding combined expertise, S.L.A. Pharma has developed a product pipeline covering familial adenomatous polyposis, anal fissures, perianal Crohn's disease, opioid induced constipation and faecal incontinence.
The in-house team at S.L.A. Pharma is composed of highly motivated and experienced pharmaceutical professionals, with expertise in all aspects of the drug development process.
Individuals have held positions of responsibility in small and large Pharma in areas including pharmaceutical development, manufacturing, clinical development, medical affairs and regulatory affairs. The team is led by a dynamic and energetic CEO who has over 15 years experience in developing medicinal products for the treatment of gastrointestinal disorders.
S.L.A. Pharma has five products at various stages of development and is currently in the process of conducting Phase II and Phase III studies throughout Europe. Previously clinical studies have been successfully completed in the US and Europe.